Anaesthesia and Pain Research Institute, Department of Anaesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Department of Anaesthesiology and Pain Medicine, National Health Insurance Service Ilsan Hospital, Goyang City, South Korea.
Paediatr Anaesth. 2021 Aug;31(8):863-870. doi: 10.1111/pan.14205. Epub 2021 Jun 3.
Although a neuromuscular blocking agent during induction of anesthesia is the standard of care in adults, some pediatric anesthesiologists remain concerned about their use for several reasons. Therefore, propofol and short-acting opioids with a moderate concentration of sevoflurane have been used as alternatives to a neuromuscular blocking agent.
This study compared propofol, alfentanil, and rocuronium to determine the optimal anesthetic agent for intubation conditions as well as emergence in a short pediatric procedure.
In this prospective, randomized, double-blind study, 114 pediatric patients, aged 1-9 years, were randomly assigned to one of three groups receiving either propofol 2 mg kg (propofol group), alfentanil 14 mcg kg (alfentanil group), or rocuronium 0.3 mg kg (rocuronium group). The primary outcome was intubating conditions, which were evaluated 90 s after test drug administration. Vital signs were recorded during the intubation period. Complications during and after emergence, time to recovery, airway-related complications, and severity of emergence agitation were recorded.
Compared with the propofol group (60%), significantly more excellent intubating conditions were observed in the alfentanil group (97%, percent difference -37, 95% confidence interval (CI) -54.4--21.0, p < .001) and the rocuronium group (87%, percent difference -27, 95% CI -46.5--8.2, p = .041). Hemodynamic responses were different between the rocuronium and alfentanil groups, although the incidence of adverse events was not different among the three groups. The emergence duration was only statistically different between the rocuronium group [9.9 ± 3.2 min] and the propofol group [11.7 ± 2.2 min] (difference 95% CI 0.667-3.583, p = .001), while that of the alfentanil group [10.9 ± 2.4 min] was comparable with the other groups.
Both 0.3 mg kg rocuronium and 14 µg kg alfentanil are superior adjuncts for tracheal intubation in children undergoing frenulectomy in comparison with 2 mg kg propofol. Hemodynamic adverse events and recovery profiles were comparable among the three groups.
尽管在成人麻醉诱导期间使用神经肌肉阻滞剂是标准的治疗方法,但由于多种原因,一些儿科麻醉师仍对其使用存在担忧。因此,丙泊酚和中浓度七氟醚与短效阿芬太尼已被用作神经肌肉阻滞剂的替代品。
本研究比较了丙泊酚、阿芬太尼和罗库溴铵,以确定在小儿短程手术中插管条件和苏醒的最佳麻醉药物。
在这项前瞻性、随机、双盲研究中,将 114 名年龄在 1-9 岁的儿科患者随机分为三组,分别接受丙泊酚 2mg/kg(丙泊酚组)、阿芬太尼 14μg/kg(阿芬太尼组)或罗库溴铵 0.3mg/kg(罗库溴铵组)。主要结局是在给予试验药物后 90s 时的插管条件。在插管期间记录生命体征。记录术中及苏醒后并发症、恢复时间、与气道相关的并发症以及苏醒躁动的严重程度。
与丙泊酚组(60%)相比,阿芬太尼组(97%,差异百分比-37,95%置信区间(CI)-54.4--21.0,p<0.001)和罗库溴铵组(87%,差异百分比-27,95%CI-46.5--8.2,p=0.041)观察到的插管条件显著更好。罗库溴铵组与阿芬太尼组之间的血流动力学反应不同,尽管三组之间的不良事件发生率无差异。罗库溴铵组[9.9±3.2min]与丙泊酚组[11.7±2.2min]的苏醒时间仅在统计学上有差异(差异 95%CI 0.667-3.583,p=0.001),而阿芬太尼组[10.9±2.4min]与其他组相当。
与 2mg/kg 丙泊酚相比,0.3mg/kg 罗库溴铵和 14μg/kg 阿芬太尼均为行系带切除术的儿童气管插管的辅助药物,效果优于丙泊酚。三组之间的血流动力学不良事件和恢复情况相似。